Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davood Bashash

Showing results (181-190 of 184) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 184 results.
Cellular Oncology (Dordrecht, Netherlands)|April 27, 2019
The ERBB receptor inhibitor dacomitinib suppresses proliferation and invasion of pancreatic ductal adenocarcinoma cellsMajid Momeny, Fatemeh Esmaeili, Sepideh Hamzehlou, et al.
Scientific Reports|April 7, 2017
Anti-tumour activity of tivozanib, a pan-inhibitor of VEGF receptors, in therapy-resistant ovarian carcinoma cellsMajid Momeny, Zahra Sabourinejad, Ghazaleh Zarrinrad, et al.
Scientific Reports|June 25, 2017
Dacomitinib, a pan-inhibitor of ErbB receptors, suppresses growth and invasive capacity of chemoresistant ovarian carcinoma cellsMajid Momeny, Ghazaleh Zarrinrad, Farima Moghaddaskho, et al.
The International Journal of Biochemistry & Cell Biology|March 24, 2018
Blockade of nuclear factor-κB (NF-κB) pathway inhibits growth and induces apoptosis in chemoresistant ovarian carcinoma cellsMajid Momeny, Hassan Yousefi, Haniyeh Eyvani, et al.
Pageof 19

Showing results (181-190 of 184) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 184 results.
Cellular Oncology (Dordrecht, Netherlands)|April 27, 2019
The ERBB receptor inhibitor dacomitinib suppresses proliferation and invasion of pancreatic ductal adenocarcinoma cellsMajid Momeny, Fatemeh Esmaeili, Sepideh Hamzehlou, et al.
Scientific Reports|April 7, 2017
Anti-tumour activity of tivozanib, a pan-inhibitor of VEGF receptors, in therapy-resistant ovarian carcinoma cellsMajid Momeny, Zahra Sabourinejad, Ghazaleh Zarrinrad, et al.
Scientific Reports|June 25, 2017
Dacomitinib, a pan-inhibitor of ErbB receptors, suppresses growth and invasive capacity of chemoresistant ovarian carcinoma cellsMajid Momeny, Ghazaleh Zarrinrad, Farima Moghaddaskho, et al.
The International Journal of Biochemistry & Cell Biology|March 24, 2018
Blockade of nuclear factor-κB (NF-κB) pathway inhibits growth and induces apoptosis in chemoresistant ovarian carcinoma cellsMajid Momeny, Hassan Yousefi, Haniyeh Eyvani, et al.
Pageof 19